Media

After matching Comirnaty, Providence plans phase 3 booster study

Written on October 26, 2022

Read more

Calgary-based Providence Therapeutics recruits for vaccine trial, secures funding for bringing jabs to developing world

Written on December 29, 2021

Read more

Providence’s COVID-19 mRNA Vaccine Challenger Seen In Phase III In Q1

Written on October 07, 2021

Read more